Literature DB >> 10834981

A comparison of seven tests for serological diagnosis of tuberculosis.

S Pottumarthy1, V C Wells, A J Morris.   

Abstract

Seven serological tests, two immunochromatographic tests, ICT Tuberculosis and RAPID TEST TB, and five enzyme-linked immunosorbent assays, TUBERCULOSIS IgA EIA, PATHOZYME-TB complex, PATHOZYME-MYCO IgG, PATHOZYME-MYCO IgA, and PATHOZYME-MYCO IgM, were evaluated simultaneously with 298 serum samples from three groups of individuals: 44 patients with active tuberculosis, 204 controls who had undergone the Mantoux test (89 Mantoux test-positive and 115 Mantoux test-negative controls), and 50 anonymous controls. The sensitivities of the tests with sera from patients with active tuberculosis were poor to modest, ranging from 16 to 57%. All the tests performed equally with sera from subgroups of those with active tuberculosis, those with pulmonary (33 patients) versus extrapulmonary (11 patients) disease, and those who were smear positive (24 patients) versus smear negative (12 patients) (P > 0.05). The specificities of the tests ranged from 80 to 97% with sera from the Mantoux test controls and 62 to 100% with sera from the anonymous controls. The TUBERCULOSIS IgA EIA had the highest sensitivity (57%) with sera from patients with active tuberculosis, with a high specificity of 93% with sera from the Mantoux test controls, but a very poor specificity of 62% with sera from the anonymous controls. Overall, ICT Tuberculosis followed by PATHOZYME-MYCO IgG had the best performance characteristics, with sensitivities of 41 and 55%, respectively, with sera from patients with active tuberculosis and specificities of 96 and 89%, respectively, with sera from the Mantoux test controls and 88 and 90%, respectively, with sera from the anonymous controls. By combining all the test results, a maximum sensitivity of 84% was obtained, with reciprocal drops in specificities to 55 and 42% for the Mantoux test controls and anonymous controls, respectively. The best combination was that of ICT Tuberculosis and PATHOZYME-MYCO IgG, with a sensitivity of 66% and a specificity of 86% for the Mantoux test controls and a sensitivity and specificity of 78% for the anonymous controls. While a negative result by any one of these tests would be useful in helping to exclude disease in a population with a low prevalence of tuberculosis, a positive result may aid in clinical decision making when applied to symptomatic patients being evaluated for active tuberculosis.

Entities:  

Mesh:

Year:  2000        PMID: 10834981      PMCID: PMC86769          DOI: 10.1128/JCM.38.6.2227-2231.2000

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  11 in total

1.  Evaluation of the recombinant 38-kilodalton antigen of Mycobacterium tuberculosis as a potential immunodiagnostic reagent.

Authors:  R J Wilkinson; K Hasløv; R Rappuoli; F Giovannoni; P R Narayanan; C R Desai; H M Vordermeier; J Paulsen; G Pasvol; J Ivanyi; M Singh
Journal:  J Clin Microbiol       Date:  1997-03       Impact factor: 5.948

2.  Evaluation of different tests for the serodiagnosis of tuberculosis and the use of likelihood ratios in serology.

Authors:  A Verbon; G J Weverling; S Kuijper; P Speelman; H M Jansen; A H Kolk
Journal:  Am Rev Respir Dis       Date:  1993-08

3.  Detection of pulmonary and extrapulmonary tuberculosis patients with the 38-kilodalton antigen from Mycobacterium tuberculosis in a rapid membrane-based assay.

Authors:  A T Zhou; W L Ma; P Y Zhang; R A Cole
Journal:  Clin Diagn Lab Immunol       Date:  1996-05

4.  Serodiagnosis of tuberculosis. A study comparing three specific mycobacterial antigens.

Authors:  I H Chiang; J Suo; K J Bai; T P Lin; K T Luh; C J Yu; P C Yang
Journal:  Am J Respir Crit Care Med       Date:  1997-09       Impact factor: 21.405

Review 5.  The serodiagnosis of tuberculosis and other mycobacterial diseases by enzyme-linked immunosorbent assay.

Authors:  T M Daniel; S M Debanne
Journal:  Am Rev Respir Dis       Date:  1987-05

6.  Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care facilities, 1994. Centers for Disease Control and Prevention.

Authors: 
Journal:  MMWR Recomm Rep       Date:  1994-10-28

7.  Evaluation of the tuberculin gamma interferon assay: potential to replace the Mantoux skin test.

Authors:  S Pottumarthy; A J Morris; A C Harrison; V C Wells
Journal:  J Clin Microbiol       Date:  1999-10       Impact factor: 5.948

8.  Evaluation of IgA-mediated humoral immune response against the mycobacterial antigen P-90 in diagnosis of pulmonary tuberculosis.

Authors:  M Alifano; R De Pascalis; M Sofia; S Faraone; M Del Pezzo; I Covelli
Journal:  Chest       Date:  1997-03       Impact factor: 9.410

Review 9.  Serological diagnosis of tuberculosis.

Authors:  G H Bothamley
Journal:  Eur Respir J Suppl       Date:  1995-09

10.  Clinical evaluation of a rapid immunochromatographic assay based on the 38 kDa antigen of Mycobacterium tuberculosis on patients with pulmonary tuberculosis in China.

Authors:  R A Cole; H M Lu; Y Z Shi; J Wang; T De-Hua; A T Zhou
Journal:  Tuber Lung Dis       Date:  1996-08
View more
  53 in total

1.  Identification, molecular cloning, and evaluation of potential use of isocitrate dehydrogenase II of Mycobacterium bovis BCG in serodiagnosis of tuberculosis.

Authors:  W Florio; D Bottai; G Batoni; S Esin; M Pardini; G Maisetta; M Campa
Journal:  Clin Diagn Lab Immunol       Date:  2002-07

2.  Evaluation of commercial enzyme-linked immunosorbent assay kits for detection of tuberculosis in Argentinean population.

Authors:  María Susana Imaz; Marcelo Alberto Comini; Elsa Zerbini; María Delfina Sequeira; Omar Latini; Juan Daniel Claus; Mahavir Singh
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

3.  Rapid serodiagnosis of active pulmonary Mycobacterium tuberculosis by analysis of results from multiple antigen-specific tests.

Authors:  Yoshinari Okuda; Ryoji Maekura; Atsusi Hirotani; Seigo Kitada; Kenji Yoshimura; Touru Hiraga; Yuoko Yamamoto; Masami Itou; Takeshi Ogura; Toshio Ogihara
Journal:  J Clin Microbiol       Date:  2004-03       Impact factor: 5.948

4.  Immunochromatographic IgG/IgM test for rapid diagnosis of active tuberculosis.

Authors:  Walid Ben-Selma; Hedi Harizi; Jalel Boukadida
Journal:  Clin Vaccine Immunol       Date:  2011-10-12

5.  Poor performance of a novel serological test for diagnosis of pulmonary tuberculosis in Bangui, Central African Republic.

Authors:  Eric Kassa-Kelembho; Edith Kassa; Germain Zandanga; Yves-Brillant Service; Albert Ignaleamoko; Antoine Talarmin
Journal:  Clin Vaccine Immunol       Date:  2006-06

6.  Mycobacterium tuberculosis malate synthase- and MPT51-based serodiagnostic assay as an adjunct to rapid identification of pulmonary tuberculosis.

Authors:  Jacqueline M Achkar; Yuxin Dong; Robert S Holzman; John Belisle; Irene S Kourbeti; Tsering Sherpa; Rany Condos; William N Rom; Suman Laal
Journal:  Clin Vaccine Immunol       Date:  2006-11

7.  Sensitivity and specificity of immunocytochemical staining of mycobacterial antigens in the cytoplasm of cerebrospinal fluid macrophages for diagnosing tuberculous meningitis.

Authors:  Yuquan Shao; Ping Xia; Tao Zhu; Jiong Zhou; Yuan Yuan; Hao Zhang; Jianjun Chen; Xingyue Hu
Journal:  J Clin Microbiol       Date:  2011-07-27       Impact factor: 5.948

8.  Humoral immune responses against the Mycobacterium tuberculosis 38-kilodalton, MTB48, and CFP-10/ESAT-6 antigens in tuberculosis.

Authors:  Xueqiong Wu; Yourong Yang; Junxian Zhang; Bangying Li; Yan Liang; Chuiying Zhang; Mei Dong; Hongbing Cheng; Jufang He
Journal:  Clin Vaccine Immunol       Date:  2010-01-06

9.  Evaluation of an in-house-developed radioassay kit for antibody detection in cases of pulmonary tuberculosis and tuberculous meningitis.

Authors:  M Kameswaran; K Shetty; M K Ray; M A Jaleel; G V Kadival
Journal:  Clin Diagn Lab Immunol       Date:  2002-09

10.  Evaluation of anti-A60 antigen IgG enzyme-linked immunosorbent assay for serodiagnosis of pulmonary tuberculosis.

Authors:  Zakeya Abdulbaqi Bukhary
Journal:  Ann Thorac Med       Date:  2007-04       Impact factor: 2.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.